C14 Regulation of cardiac glycolysis by adenosine
✍ Scribed by Jorge Suárez; Rafael Rubio
- Publisher
- Elsevier Science
- Year
- 1992
- Tongue
- French
- Weight
- 152 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0985-0562
No coin nor oath required. For personal study only.
✦ Synopsis
and specific binding sites for the A~ antagonist [3H]DPCPX. The rank order of affinities of various adenosine egonists and antagonists confirmed the identity of the cDNA clone. Binding of agonists was sensitive to the presence of the nonhydrelyzable GTP analog, GppNHp. In edenylyl cyclase essays, adenosine agonists inhibited forskolin-stimulated cAMP production by 50%. Northern and in situ hybddizafion analyses of receptor mRNA in brain tissues revealed two transcripts of 5.6 and 3.1 kb. Both were abundant in cortex, cerebellum, hippocampus and thalamus, with lower levels in olfactory bulb, striatum, mesencephaion and retina. This distribution is in good agreement with receptor autoradiographic atddies of the A~ adenosine receptor. A~ receptor mRNA appears first at mid-embryogenesis (Ef5-17) in lower brain regions (pens, medulla) and in spinal cord. By E2.1 mRNA distribution is abundant and spread throughout the CNS, similar to adult.
📜 SIMILAR VOLUMES
## RESUM]~S DES COMMUNICATIONS : AD]~NOS1NE thus, tissue specific differences in adenosine receptor subtypes that have been proposed on the bases of subtle pharmacological differences in ligand binding have not yet been identified. All of the adenosine receptors couple to GTP binding proteins and.
Incubation of C6 glioma cells in the presence of aminoglutethimide, an inhibitor of cholesterol metabolism, together with either adenosine 3',5'-cyclic monophosphate (CAMP) analogues or agents that increase CAMP synthesis, such as cholera toxin, forskolin, and isoproterenol, stimulated the rate of p